Vistagen Therapeutics, Inc. (VTGN)

NASDAQ: VTGN · Real-Time Price · USD

0.2838

-0.0132 (-4.44%)

At close: Aug 6, 2026, 4:00 PM EDT

0.2757

-0.0081 (-2.85%)

Pre-market: Aug 7, 2026, 6:13 AM EDT

Vistagen Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	30.79	67.13	119.17	16.64	68.14
Short-Term Investments	14.61	13.35	-	-	-
Cash & Short-Term Investments	45.4	80.48	119.17	16.64	68.14
Cash Growth	-43.59%	-32.46%	616.23%	-75.58%	-33.92%
Other Current Assets	1.54	1.59	1.51	0.87	2.86
Total Current Assets	46.94	82.08	120.67	17.51	71
Net Property, Plant & Equipment	1.23	1.81	2.26	2.77	3.08
Other Long-Term Assets	0.39	0.45	0.73	0.82	0.57
Total Assets	48.56	84.34	123.65	21.09	74.64
Accounts Payable	1.54	0.65	1.55	2.47	2.76
Accrued Expenses	8.76	8.81	2.24	0.8	1.33
Short-Term Debt	0.1	-	-	0.11	-
Current Portion of Leases	0.7	0.56	0.55	0.49	0.43
Unearned Revenue	1.71	2.59	0.79	0.71	1.24
Total Current Liabilities	12.8	12.61	5.12	4.57	5.77
Long-Term Leases	0.25	0.95	1.57	2.12	2.61
Other Long-Term Liabilities	-	0.39	2.67	2.32	1.56
Total Long-Term Liabilities	0.25	1.34	4.24	4.44	4.16
Total Liabilities	13.04	13.95	9.37	9.01	9.93
Common Stock	-	-	0.03	0.01	0.01
Treasury Stock	-3.97	-3.97	-3.97	-3.97	-3.97
Additional Paid-in Capital	516.77	481.96	474.44	342.89	336.28
Accumulated Other Comprehensive Income	-0	0.01	-	-	-
Retained Earnings	-477.32	-407.63	-356.21	-326.85	-267.6
Shareholders' Equity	35.52	70.39	114.29	12.08	64.72
Total Liabilities & Equity	48.56	84.34	123.65	21.09	74.64
Total Debt	1.04	1.51	2.12	2.71	3.04
Net Cash (Debt)	44.36	78.97	117.05	13.93	65.1
Net Cash Growth	-43.83%	-32.53%	740.43%	-78.61%	-34.50%
Net Cash Per Share	1.17	2.56	6.05	2.00	9.86
Book Value	35.52	70.39	114.29	12.08	64.72
Book Value Per Share	0.93	2.28	5.90	1.74	9.81
Tangible Book Value	35.52	70.39	114.29	12.08	64.72
Tangible Book Value Per Share	0.93	2.28	5.90	1.74	9.81

SEC Filings: 10-K · 10-Q